Stable growth hormone compounds resistant to proteolytic degradation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9211342
APP PUB NO 20130040883A1
SERIAL NO

13574128

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to growth hormone (GH) compounds having additional disulphide bridges and at least one additional single point mutation making the compounds resistant to proteolytic degradation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVO NORDISK HEALTHCARE AGTHURGAUERSTRASSE 36/38 ZURICH CH-8050

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Jianhe Beijing, CN 18 81
Demuth, Helle Rungsted kyst, DK 5 41
Noerskov-Lauritsen, Leif Tappernoeje, DK 12 40
Schioedt, Christine Brunn Broenshoej, DK 1 5
Thygesen, Peter Copenhagen OE, DK 7 97

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 15, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00